To evaluate tumor burden using a bioluminescent model, we then treated mice engrafted with DMG model 7316-6349 injected into the pons with 4 repeated doses of 4 × 106 mRNA GD2-directed CAR T cells or CD19-directed controls. The gene discussed is CD19; the disease is neoplasm.